These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 30127781)

  • 1. The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond.
    Brembilla NC; Senra L; Boehncke WH
    Front Immunol; 2018; 9():1682. PubMed ID: 30127781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.
    Matsuzaki G; Umemura M
    Microbiol Immunol; 2018 Jan; 62(1):1-13. PubMed ID: 29205464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies.
    Brembilla NC; Boehncke WH
    Front Immunol; 2023; 14():1186455. PubMed ID: 37283755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 inhibitors for psoriasis.
    Paek SY; Frieder J; Kivelevitch D; Menter MA
    Semin Cutan Med Surg; 2018 Sep; 37(3):148-157. PubMed ID: 30215631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
    Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
    J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IL-17 in psoriasis.
    Malakouti M; Brown GE; Wang E; Koo J; Levin EC
    J Dermatolog Treat; 2015 Feb; 26(1):41-4. PubMed ID: 24552504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications.
    von Stebut E; Boehncke WH; Ghoreschi K; Gori T; Kaya Z; Thaci D; Schäffler A
    Front Immunol; 2019; 10():3096. PubMed ID: 32010143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer.
    Brevi A; Cogrossi LL; Grazia G; Masciovecchio D; Impellizzieri D; Lacanfora L; Grioni M; Bellone M
    Front Immunol; 2020; 11():565470. PubMed ID: 33244315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.
    Fletcher JM; Moran B; Petrasca A; Smith CM
    Clin Exp Immunol; 2020 Aug; 201(2):121-134. PubMed ID: 32379344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
    Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
    Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ixekizumab for treatment of psoriasis.
    Dyring-Andersen B; Skov L; Zachariae C
    Expert Rev Clin Immunol; 2015 Apr; 11(4):435-42. PubMed ID: 25748485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis.
    AbuHilal M; Walsh S; Shear N
    J Cutan Med Surg; 2016 Nov; 20(6):509-516. PubMed ID: 27207350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional specialization of interleukin-17 family members.
    Iwakura Y; Ishigame H; Saijo S; Nakae S
    Immunity; 2011 Feb; 34(2):149-62. PubMed ID: 21349428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders.
    Balato A; Scala E; Balato N; Caiazzo G; Di Caprio R; Monfrecola G; Raimondo A; Lembo S; Ayala F
    Expert Opin Biol Ther; 2017 Nov; 17(11):1363-1374. PubMed ID: 28791896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of IL-17A blockade in psoriasis.
    Puig L; Carrascosa JM
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():1-5. PubMed ID: 25398486
    [No Abstract]   [Full Text] [Related]  

  • 19. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.
    Blauvelt A; Chiricozzi A
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):379-390. PubMed ID: 30109481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.
    van den Berg WB; McInnes IB
    Semin Arthritis Rheum; 2013 Oct; 43(2):158-70. PubMed ID: 24157091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.